Atlas Trials

Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer

Clinical trial NCT03186326 · COMPLETED

Trial details

NCT number
NCT03186326
Sponsor
Federation Francophone de Cancerologie Digestive
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal CancerMSI
Start date
2018-04-24
Primary completion
2022-05-31
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.